A new study by researchers at the Baker Heart and Diabetes Institute and Monash University could help inform treatment and prevent serious events like a heart attack or death in diabetic patients at high risk of serious cardiovascular ...
Jan 3, 2022
0
88
New research could form the basis for developing life-changing therapies that limit the impact of diabetic eye disease—a condition that could potentially affect some 1.7 million Australians, suffering from type 1 and type ...
Dec 20, 2021
0
78
A newly discovered hormone named fabkin helps regulate metabolism and may play an important role in the development of both type 1 and type 2 diabetes, according to research led by the Sabri Ülker Center for Metabolic Research ...
Dec 8, 2021
0
180
Interim results from a multicenter clinical trial demonstrate insulin secretion from engrafted cells in patients with type 1 diabetes. The safety, tolerability, and efficacy of the implants, which consisted of pancreatic ...
Dec 2, 2021
0
108
An experimental compound reduced complications of type 1 and type 2 diabetes in mice—not by lowering blood sugar—but by countering its consequences: cell death, inflammation, and organ damage.
Nov 24, 2021
0
67
Wright State University researchers have identified a molecule that disrupts a highly specialized structure in neurons from the brain, a finding that could broaden the understanding of neurological complications in diseases.
Nov 23, 2021
0
94
Eliminating old, dysfunctional cells in human fat also alleviates signs of diabetes, researchers from UConn Health report. The discovery could lead to new treatments for Type 2 diabetes and other metabolic diseases.
Nov 22, 2021
0
218
Identical twins share the same DNA, but one twin can suffer from type 2 diabetes while the other twin does not develop the disease. A study led by Lund University in Sweden has now discovered that there are differences in ...
Nov 22, 2021
0
55
Yale researchers have developed an oral medication to treat diabetes that controls insulin levels while simultaneously reversing the inflammatory effects of the disease.
Nov 16, 2021
1
174
When the pro-inflammatory pair, a receptor called CCR2 and its ligand CCL-2, get together, it increases the risk of developing type 1 diabetes, scientists report.
Nov 16, 2021
0
110
